Financhill
Back

IGC Pharma 10K Form

Sell
32

IGC
IGC Pharma

Last Price:
0.38
Seasonality Move:
-8.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGC News And Ratings

See the #1 stock for the next 7 days that we like better than IGC

IGC Financial Statistics

Sales & Book Value

Annual Sales: $1.35M
Cash Flow: $-1.88M
Price / Cash Flow: 0
Annual Sales: $0.10
Price / Book: 3.66

Profitability

EPS (TTM): -0.21000
Net Income (TTM): $-13.3M
Gross Margin: $733K
Return on Equity: -129.02%
Return on Assets: -104.04%

IGC Pharma Earnings Forecast

Key IGC Pharma Financial Ratios

  • The Gross Profit Margin over the past 17 years for IGC is 54.50%.
  • The Selling, General & Administrative Expenses for IGC have been equal to 502.45% of Gross Profit Margin.
  • The Research & Development expenses have been 280.52% of Revenue.
  • The Interest Expense is -1.68% of Operating Income.
  • The Net Earning history of IGC is -966.54% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

IGC Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: IGC
CUSIP: 45408X
Website: igcinc.us

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.77
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGC Technical Analysis vs Fundamental Analysis

Sell
32
IGC Pharma (IGC) is a Sell

Is IGC Pharma a Buy or a Sell?

  • IGC Pharma stock is rated a Sell
    The current IGC Pharma [IGC] share price is $0.38. The Score for IGC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.